Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
1.410
-0.050 (-3.42%)
At close: Mar 28, 2025, 4:00 PM
1.417
+0.007 (0.48%)
After-hours: Mar 28, 2025, 7:50 PM EDT

Ironwood Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Revenue
351.41442.74410.6413.75389.52
Upgrade
Revenue Growth (YoY)
-20.63%7.83%-0.76%6.22%-9.08%
Upgrade
Cost of Revenue
109.96104.7944.2770.4191.2
Upgrade
Gross Profit
241.46337.95366.33343.35298.33
Upgrade
Selling, General & Admin
144.01142.11115.99111.13140
Upgrade
Operating Expenses
144.01142.11115.99111.13140
Upgrade
Operating Income
97.44195.84250.34232.22158.32
Upgrade
Interest Expense
-33.04-21.63-7.6-31.15-29.48
Upgrade
Interest & Investment Income
4.4718.979.50.731.5
Upgrade
Other Non Operating Income (Expenses)
-0.020.18-1.18-6.11
Upgrade
EBT Excluding Unusual Items
68.88193.2252.42200.61124.24
Upgrade
Merger & Restructuring Charges
-2.59-45.82-0.04-15.38
Upgrade
Pretax Income
66.28-948.07252.42200.66108.86
Upgrade
Income Tax Expense
64.4783.4977.36-327.792.69
Upgrade
Earnings From Continuing Operations
1.81-1,032175.07528.45106.18
Upgrade
Net Income to Company
1.81-1,032175.07528.45106.18
Upgrade
Minority Interest in Earnings
-29.32---
Upgrade
Net Income
1.81-1,002175.07528.45106.18
Upgrade
Net Income to Common
1.81-1,002175.07528.45106.18
Upgrade
Net Income Growth
---66.87%397.71%393.73%
Upgrade
Shares Outstanding (Basic)
181155154162159
Upgrade
Shares Outstanding (Diluted)
181155186164161
Upgrade
Shares Change (YoY)
16.64%-16.57%13.32%2.34%2.97%
Upgrade
EPS (Basic)
0.01-6.451.133.260.67
Upgrade
EPS (Diluted)
0.01-6.450.963.210.66
Upgrade
EPS Growth
---69.98%386.36%378.84%
Upgrade
Free Cash Flow
-183.15273.63261.63166.99
Upgrade
Free Cash Flow Per Share
-1.181.471.591.04
Upgrade
Gross Margin
68.71%76.33%89.22%82.98%76.59%
Upgrade
Operating Margin
27.73%44.23%60.97%56.12%40.64%
Upgrade
Profit Margin
0.52%-226.37%42.64%127.72%27.26%
Upgrade
Free Cash Flow Margin
-41.37%66.64%63.23%42.87%
Upgrade
EBITDA
99.48197.41251.76233.74160.69
Upgrade
EBITDA Margin
28.31%44.59%61.31%56.49%41.25%
Upgrade
D&A For EBITDA
2.031.581.421.522.36
Upgrade
EBIT
97.44195.84250.34232.22158.32
Upgrade
EBIT Margin
27.73%44.23%60.97%56.12%40.64%
Upgrade
Effective Tax Rate
97.27%-30.65%-2.47%
Upgrade
Revenue as Reported
351.41442.74410.6413.75389.52
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q